Transaction specifics
Robert Chatwani, who serves as President General Manager, Growth at DocuSign (NASDAQ: DOCU), sold 17,492 shares of the company’s common stock on March 18, 2026. The disposals were carried out in several transactions at prices ranging from $45.25 to $49.80 per share, producing aggregate proceeds of approximately $803,042. The trades were implemented under a Rule 10b5-1 trading plan.
Post-sale ownership and market moves
After these sales, Chatwani directly holds 72,458 shares of DocuSign. The company’s stock is trading at $47.75 at the time of the report, reflecting a decline of 44% over the past year and a 30% decline year-to-date.
Valuation note
InvestingPro’s analysis, cited in available reporting, indicates DocuSign appears undervalued on its Fair Value assessment. The platform is noted as providing detailed insights into the company’s financial position and growth prospects.
Quarterly results and analyst responses
DocuSign released fourth-quarter fiscal 2026 results showing earnings per share of $1.01, ahead of the $0.95 consensus estimate. Revenue in the quarter was $837 million, topping the $827.9 million expectation. Following the earnings beat, several analyst firms adjusted their price targets and reiterated or changed ratings.
RBC Capital lowered its price target to $55 from $70 while maintaining a Sector Perform rating, observing that fiscal 2027 guidance met or slightly exceeded expectations but that operating margin guidance was modestly below forecasts. UBS trimmed its target to $54 from $75 and kept a Neutral rating, citing concerns about the growth outlook. Piper Sandler reduced its target to $52 from $75, while emphasizing solid fourth-quarter results and potential growth in annual recurring revenue. Citizens cut its price target to $86 from $124 and maintained a Market Outperform rating, noting the company’s substantial customer base and market potential.
Context and implications
The insider sale, executed through a prearranged plan, coincides with reported outperformance in the most recent quarter and a series of analyst target revisions that reflect differing views on growth and margin trajectories. The market reaction to the company’s stock performance and analyst updates is evident in the year-over-year and year-to-date share-price declines noted above.
Note: The article reflects the transaction details, financial results, analyst actions, and valuation commentary available in the reported information. Where data or commentary was limited in scope, the piece does not infer additional causes or outcomes beyond what was provided.